Dahai Jiang

Postdoctoral Fellow

  • 387 Citations
  • 8 h-Index
20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Polyethyleneimine Medicine & Life Sciences
Tumors Chemical Compounds
Small Interfering RNA Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

  • 387 Citations
  • 8 h-Index
  • 14 Article
  • 1 Chapter

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K. & Lopez, G., Jan 1 2019, (Accepted/In press) In : EBioMedicine.

Research output: Contribution to journalArticle

Prostaglandin Receptors
Dinoprostone
Cisplatin
Ovary
Carcinogenesis

Inhibiting nuclear phospho-progesterone receptor enhances antitumor activity of onapristone in uterine cancer

Huang, Y., Hu, W., Huang, J., Shen, F., Sun, Y., Ivan, C., Pradeep, S., Dood, R., Haemmerle, M., Jiang, D., Mangala, L. S., Noh, K., Hansen, J. M., Dalton, H. J., Previs, R. A., Nagaraja, A. S., McGuire, M., Jennings, N. B., Broaddus, R., Coleman, R. & 1 othersSood, A. K., Feb 1 2018, In : Molecular cancer therapeutics. 17, 2, p. 464-473 10 p.

Research output: Contribution to journalArticle

Uterine Neoplasms
Progesterone Receptors
Epidermal Growth Factor
Ligands
onapristone
8 Citations

MYC targeted long noncoding RNA DANCR promotes cancer in part by reducing p21 levels

Lu, Y., Hu, Z., Mangala, L. S., Stine, Z. E., Hu, X., Jiang, D., Xiang, Y., Zhang, Y., Pradeep, S., Rodriguez-Aguayo, C., Lopez, G., DeMarzo, A. M., Sood, A. K., Zhang, L. & Dang, C. V., Jan 1 2018, In : Cancer Research. 78, 1, p. 64-74 11 p.

Research output: Contribution to journalArticle

Long Noncoding RNA
Neoplasms
Cell Proliferation
Ovarian Neoplasms
Modifier Genes
5 Citations

Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation

Zheng, Y., Sethi, R., Mangala, L. S., Taylor, C., Goldsmith, J., Wang, M., Masuda, K., Karaminejadranjbar, M., Mannion, D., Miranda, F., Herrero-Gonzalez, S., Hellner, K., Chen, F., Alsaadi, A., Albukhari, A., Fotso, D. C., Yau, C., Jiang, D., Pradeep, S., Rodriguez-Aguayo, C. & 11 othersLopez, G., Knapp, S., Gray, N. S., Campo, L., Myers, K. A., Dhar, S., Ferguson, D., Bast Jr, R. C., Sood, A. K., Von Delft, F. & Ahmed, A. A., Dec 1 2018, In : Nature communications. 9, 1, 476.

Research output: Contribution to journalArticle

phosphorylation
Phosphorylation
Paclitaxel
Microtubules
therapy

Chitosan nanoparticles for miRNA delivery

Denizli, M., Aslan, B., Mangala, L. S., Jiang, D., Rodriguez-Aguayo, C., Lopez, G. & Sood, A. K., Jan 1 2017, Methods in Molecular Biology. Humana Press Inc., p. 219-230 12 p. (Methods in Molecular Biology; vol. 1632).

Research output: Chapter in Book/Report/Conference proceedingChapter

Chitosan
MicroRNAs
Nanoparticles
RNA Interference
Intravenous Administration